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Background:  A minority of patients with heart failure (HF) who undergo ICD implantation receive life-saving ICD therapy. Tools that can better 
risk-stratify ICD candidates and predict which patients are at low risk for serious arrhythmias who are unlikely to benefit from ICD implantation are 
needed. We examined whether cardiac mIBG scintigraphy can identify a subset of HF patients who are at low risk of life-threatening arrhythmias, in 
whom ICD implantation could potentially be deferred.
Methods:  Data was analyzed from the ADMIRE-HF study, a multicenter study of the prognostic utility of cardiac mIBG scanning in HF patients. The 
study enrolled 938 patients (all with LVEF≤35% and HF class II or III) who underwent resting myocardial perfusion and mIBG scanning at baseline. 
Patients were followed prospectively for the occurrence of heart failure progression and arrhythmic events for a median of 17 months. The endpoint 
of the present analysis was serious arrhythmic events (SAE), a composite of sudden cardiac death, appropriate ICD therapy and sustained ventricular 
tachycardia. Multivariate regression was used to determine independent predictors of SAE. Examined variables included heart to mediastinum ratio 
(HMR) of mIBG uptake (a measure of relative myocardial sympathetic nerve activity) and perfusion summed rest score (SRS, an indicator of the 
extent of myocardial scar) quantified using the Emory Cardiac Toolbox. Event rates were compared using Kaplan-Meier method.
Results:  SAE occurred in 85 patients (9.1%). HMR was an independent predictor of SAE (HR 0.3, 95%CI [0.13-0.68], p=0.004). Patients with 
HMR >1.6 had a lower rate of SAE compared to those with HMR ≤1.6 (3.5 vs 10.5%). The combination of HMR and SRS separated patients with and 
without SAE. Among patients with SRS ≤ 8, SAE rates were 0 and 9.7% for those with HMR > 1.6 or HMR ≤ 1.6, respectively (p=0.04).
Conclusion:  HMR in mIBG scintigraphy is an independent predictor of SAE in HF patients. Combining HMR with SRS from perfusion scans 
identifies a subset of ADMIRE-HF patients at very low risk of SAE. If confirmed in dedicated prospective studies, this assessment approach could 
significantly reduce annual unnecessary ICD-related morbidity and costs.
